At present, these weight-loss drugs are widely available through pharmacists, but expensive to patients. They vary somewhat in price but all well over £100 for the basic dose.
Asda Online Doctor, for instance, lists Mounjaro starting at £168.97 for four doses. This covers a month. That’s at a basic level so can rise according to need.
Streeting believes the cost is a barrier that makes it, essentially, a two-tier health system – one for the haves and one for the have nots.
Read more:
“The wealthy talk about how they’ve transformed their health, their confidence, their quality of life. But
what about the millions who can’t afford them?
“That is a return to the days when health was determined by wealth. When some had access to the best care money can buy, while others waited and suffered. And I say: never again,” he said, insistently.
Advertising helps fund Big Issue’s mission to end poverty
The exact cost is unknown. It had previously been announced that some jabs will be available to more people on the NHS in England over the next three years.
But due to Donald Trump’s tariff jiggery-pokery, costs of Mounjaro have risen steeply in recent times. It’s unclear where they’ll settle.
To expand from tens of thousands to hundreds of thousands would put much more pressure on a creaking NHS.
An argument can be made that this is an investment in the future. If it was prescribed, costs to treat diseases related to obesity and excess weight – like type 2 diabetes and heart conditions – would drop.
It could dramatically, and quickly, improve the lifestyle and outcomes of many people. Some in government will start to talk about the potential for improving productivity in work and moving some people from long-term sick.
This is laudable. But it doesn’t seem sustainable. It doesn’t deal with underlying issues, around diet, income and other socio-economic factors that can contribute to obesity.
Advertising helps fund Big Issue’s mission to end poverty
The ongoing questions about lasting effects of weight-loss jabs also remain unanswered.
Maybe Wes Streeting will see his plan change Britain for good. It would certainly be popular. The government could do with any positive goals they can score.
It’s symptom not the cause, though. And that eventually is going to come unstuck.
Paul McNamee is editor of the Big Issue. Read more of his columns here. Follow him on X.
Do you have a story to tell or opinions to share about this? Get in touch and tell us more.
Reader-funded since 1991 – Big Issue brings you trustworthy journalism that drives real change.
Advertising helps fund Big Issue’s mission to end poverty
Every day, our journalists dig deeper, speaking up for those society overlooks.
Could you help us keep doing this vital work? Support our journalism from £5 a month.